(Reuters) -U.S. drugmaker Eli Lilly and Co said on Tuesday it would continue to supply drugs for urgent medical conditions such as cancer and diabetes to Russia, but will suspend all investments and no longer start new clinical studies in the country.
The company said it has also suspended promotional activities and export of non-essential medicines to Russia, without naming these drugs.
Pfizer Inc and Germany’s Bayer said on Monday they would maintain a humanitarian supply of medicines to Russia, but would pull back from other non-essential spending in the country.
Any profits from continued sales in Russia will be donated to organizations dedicated to humanitarian relief, Lilly said.
(Reporting by Manojna Maddipatla in Bengaluru; Editing by Krishna Chandra Eluri)
